Document Classification

Section Type: RESULTS

Text: There was no significant difference between trapidil and placebo-treated patients regarding in-stent neointimal volume (108. 6 + / - 95. 6 mm (3) vs 93. 3 + / -79. 1 mm (3) ;P = 0. 16) or % obstruction volume (38 + / -18 % vs 36 + / -21 % ;P = 0. 32), in angiographic minimal luminal diameter at follow-up (1. 63 + / -0. 61 mm vs 1. 74 + / -0. 69 mm ;P = 0. 17), restenosis rate (31 % vs 24 % ;P = 0. 24), cumulative incidence of major adverse cardiac events at 7 months (22 % vs 20 % ;P = 0. 71) or anginal complaints (30 % vs 24 % ;P = 0. 29).